Type I von Willebrand's disease presenting as recurrent corpus hemorrhagicum

Obstetrics and Gynecology

Volumn 99, Issue 5 SUPPL. 1, 2002, Pages 887-888

  Jarvis, Raymond R ^a   Olsen, Martin E ^b,c  

^a Norton Womens Group   (United States)

^b East Tennessee State University   (United States)

^c EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CYCLOPHOSPHAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; RISTOCETIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING DISORDER; BLEEDING TIME; CASE REPORT; CLINICAL FEATURE; CORPUS LUTEUM; DISEASE COURSE; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOPERITONEUM; HUMAN; LAPAROTOMY; MENORRHAGIA; NEPHROTIC SYNDROME; OVARY CYST; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; ULTRASOUND; VON WILLEBRAND DISEASE;

ADULT; FEMALE; HEMOPERITONEUM; HUMANS; OVARIAN CYSTS; VON WILLEBRAND DISEASE;

EID: 0036227129     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01627-1     Document Type: Article

References (6)

1. Benign gynecologic lesions
2. Coagulation factor deficiencies
3. Two genetic variants of von Willebrand's disease
4. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia
5. Estrogens and surgery in women with von Willebrand's disease